Title:
キラー免疫グロブリン様受容体（ＫＩＲ）ファミリーのシグナル伝達を標的とするモノクローナル抗体
Document Type and Number:
Japanese Patent JP7100365
Kind Code:
B2
Abstract:
Monoclonal antibodies derived from the native human repertoire that bind the extracellular portion of Killer IgG Receptor (KIR) and pharmaceutical and veterinary compositions thereof are useful in treating cancer in human and other subjects.
Inventors:
Esters, Angels
Gishitsuki, Mikhail
Lizar, Stephan
Cowvar, Lawrence M
Gishitsuki, Mikhail
Lizar, Stephan
Cowvar, Lawrence M
Application Number:
JP2018569121A
Publication Date:
July 13, 2022
Filing Date:
June 12, 2017
Export Citation:
Assignee:
Trellis Bioscience Incorporated
International Classes:
C12N15/13; A61K39/395; A61K45/00; A61P35/00; C07K16/28; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63; C12P21/08
Domestic Patent References:
| JP2014520092A | ||||
| JP2008506368A |
Foreign References:
| WO2016069589A1 |
Attorney, Agent or Firm:
Osamu Yamamoto
Toru Miyamae
Junichi Matsuo
Yukiko Kunieda
Toru Miyamae
Junichi Matsuo
Yukiko Kunieda
Previous Patent: Fluid controller anomaly detector, anomaly detection system, anomaly detection method, and fluid con...
Next Patent: 斜配向クロスフイルム
Next Patent: 斜配向クロスフイルム